Centenial Surgical Suture Ltd.

As of June 30, 2026, Centenial Surgical Suture Ltd. carries a market capitalization of 280.37M, placing it among publicly traded companies globally. Its enterprise value stands at 280.37M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Centenial Surgical Suture Ltd. has 3.65M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, Centenial Surgical Suture Ltd. trades at an EV/EBITDA multiple of 4.64 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 0.50 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 13.52 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 280.37M versus a market cap of 280.37M, with the gap driven by net debt and cash on the balance sheet.

These figures are as of June 30, 2026.

These figures cover the twelve months ended June 30, 2026. The company generates approximately 2.06M in revenue per employee across its workforce of 273.00, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, Centenial Surgical Suture Ltd. recorded 3.81M in income tax expense. The company reported a pretax loss of -10.62M and -14.43M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 23, 2026, Centenial Surgical Suture Ltd.'s stock has declined approximately 36.41% over the past 52 weeks. The 50-day moving average sits at 90.17, while the 200-day moving average is 92.00.

Over the twelve months ended June 30, 2026, Centenial Surgical Suture Ltd. generated 562.47M in revenue and converted that into -14.43M in net income, yielding earnings per share of -3.85. EBITDA reached 60.42M, while operating income came in at 20.74M.

Over the twelve months ended June 30, 2026, Centenial Surgical Suture Ltd. posted a gross margin of 64.35, reflecting its pricing power and cost economics. The operating margin of 3.69 and net profit margin of -2.57 provide insight into operational efficiency.